Group 1 - The company announced that its wholly-owned subsidiary, World, intends to acquire a 45.08% stake in Baimaisi (Xiamen) from related party He Xizhong for 3.7645 million yuan, which constitutes a related party transaction but does not qualify as a major asset restructuring [1] - The acquisition has been approved by the company's 21st meeting of the third board of directors, with three related directors abstaining from the vote [1] - Baimaisi (Xiamen) specializes in the sales and promotion of medical consumables, reporting revenue of 8.6912 million yuan and a net profit of 439,700 yuan for the year ending September 2025 [1] Group 2 - From the beginning of 2025 until the announcement date, the company has engaged in related party transactions totaling 12.2015 million yuan with the related party [1]
大博医疗:全资子公司拟376.45万元收购关联方45.08%股权